NASDAQ$RGEN
Repligen Corp · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Reported record quarterly revenue and organic growth, driven by gene therapy accounts and strength in chromatography and filtration franchises.
Repligen Corporation reported a 25% year-over-year increase in revenue, reaching $76.1 million in Q1 2020. The company's GAAP earnings per share increased to $0.18, and adjusted EPS grew to $0.32. The company is maintaining its full year revenue guidance.
- Revenue increased by 25% year-over-year to $76.1 million, with 16% organic growth.
- GAAP gross margin increased to 58.0%, a year-over-year increase of 220 bps.
- Adjusted gross margin increased to 58.5%, a year-over-year increase of 250 bps.
- GAAP fully diluted EPS increased to $0.18 compared to $0.17 for the first quarter of 2019.
Headline financials
Revenue & EPS history
Repligen · Revenue · Quarterly
$76.1M
Revenue by segment
Repligen · $76.1M total across 2 segments · Q1 2020
- Product Revenue$76.1M—100.0%
- Royalty and Other$30K—0.0%
Forward guidance
Repligen is maintaining its previous guidance for revenue in the range of $309-$319 million, reflecting overall revenue growth of 14%-18% and organic growth of 10%-14%.
Tailwinds
- Revenue in the range of $309-$319 million, reflecting overall revenue growth of 14%-18% and organic growth of 10%-14%.
- Gross margin is expected to be 56%-57% on both a GAAP and non-GAAP basis, an increase from our previous guidance of 55%-56%.
- Income from operations is expected to be in the range of $52-$56 million on a GAAP basis, an increase from our previous guidance of $50-$54 million.
- Adjusted (non-GAAP) income from operations is expected to be in the range of $72-$76 million, an increase from our previous guidance of $70-$74 million.
- Net income is expected to be in the range of $34.5-$37.5 million on a GAAP basis, an increase from our previous guidance of $33.5-$36.5 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
+2.6%
Avg return
Earnings day
+3.4%
Avg return
5 days after
+4.4%
Avg return
30 days after
59%
36 / 61 earnings
Positive
+22.1%
Q3 2018
Best reaction
-23.0%
Q3 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | -7.8% | -2.7% | |
| Q4 2025 | +1.4% | -4.9% | -15.5% | |
| Q3 2025 | -5.9% | -7.5% | +6.3% | |
| Q1 2025 | -2.9% | -1.5% | -14.8% | |
| Q4 2024 | +7.9% | +7.1% | -7.1% | |
| Q3 2024 | +7.9% | -10.6% | +11.8% | |
| Q2 2024 | +21.3% | +17.2% | +9.2% | |
| Q1 2024 | +1.3% | +2.3% | -9.2% | |
| Q4 2023 | -3.2% | -4.0% | -0.9% | |
| Q3 2023 | +15.1% | +31.7% | +37.7% | |
| Q2 2023 | +1.1% | +2.5% | +5.2% | |
| Q1 2023 | +6.4% | +4.3% | +8.8% | |
| Q4 2022 | +3.2% | -2.7% | -10.0% | |
| Q3 2022 | -6.0% | -4.5% | +3.1% | |
| Q2 2022 | +13.1% | +15.9% | +0.6% | |
| Q1 2022 | +7.8% | +11.4% | +19.3% | |
| Q4 2021 | -1.8% | -1.4% | +4.0% | |
| Q3 2021 | +7.2% | +11.7% | +5.5% | |
| Q2 2021 | +14.2% | +19.3% | +32.4% | |
| Q1 2021 | -6.4% | -9.8% | -15.6% | |
| Q4 2020 | +0.3% | +7.4% | -11.1% | |
| Q3 2020 | +8.1% | +0.0% | +0.8% | |
| Q2 2020 | +8.7% | +12.8% | +8.2% | |
| Q1 2020 | +6.7% | +11.9% | +5.0% | |
| Q4 2019 | -10.1% | -22.2% | -18.7% | |
| Q3 2019 | +9.9% | +6.1% | +15.1% | |
| Q2 2019 | -4.0% | -3.2% | -1.7% | |
| Q1 2019 | +2.5% | -0.2% | +11.5% | |
| Q4 2018 | -0.2% | +1.0% | -0.2% | |
| Q3 2018 | +22.1% | +25.2% | +19.3% | |
| Q2 2018 | -1.0% | +2.0% | +14.2% | |
| Q1 2018 | +5.1% | +10.2% | +14.9% | |
| Q4 2017 | +9.2% | +9.5% | +6.2% | |
| Q3 2017 | -7.1% | -13.0% | -4.9% | |
| Q2 2017 | +1.3% | +4.4% | +6.1% | |
| Q1 2017 | +5.2% | +6.3% | +11.7% | |
| Q4 2016 | +6.3% | +6.4% | +13.6% | |
| Q3 2016 | -4.1% | -1.1% | +10.0% | |
| Q2 2016 | -0.6% | -1.1% | +3.9% | |
| Q1 2016 | +2.1% | — | — | |
| Q4 2015 | +2.4% | — | — | |
| Q3 2015 | -23.0% | — | — | |
| Q2 2015 | -0.2% | — | — | |
| Q1 2015 | +16.9% | — | — | |
| Q4 2014 | +14.9% | — | — | |
| Q3 2014 | -6.6% | — | — | |
| Q2 2014 | -3.6% | — | — | |
| Q1 2014 | +5.0% | — | — | |
| Q4 2013 | -8.8% | — | — | |
| Q3 2013 | +8.8% | — | — | |
| Q2 2013 | -0.1% | — | — | |
| Q1 2013 | +2.9% | — | — | |
| Q3 2010 | -5.0% | — | — | |
| Q4 2012 | +5.8% | — | — | |
| Q3 2012 | +10.2% | — | — | |
| Q2 2012 | -0.4% | — | — | |
| Q4 2010 | -1.5% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q2 2011 | -0.1% | — | — | |
| Q1 2011 | -0.9% | — | — | |
| Q4 2011 | -0.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro